Decontamination innovation
tasks are done correctly, Lean encourages teams to question why tasks are done at all. This can help lead some departments to redesign entire workflows, relocate equipment for improved ergonomics, and introduce standardised instrument-tracking practices. Automation is also shifting the landscape.
Intelligent washer-disinfector loading systems, barcode-based cycle selection, and autonomous material-movement technologies reduce the need for repetitive manual tasks. While these systems do not replace staff, they enable teams to redirect their time toward more complex activities, such as manual cleaning of intricate devices or quality checks. Simulation-based learning offers another
advantage. Particularly within endoscope decontamination – one of the most risk-sensitive procedures, realistic training environments allow staff to practise rare or high-risk scenarios without compromising clinical operations.
3. Keeping pace with evolving standards Regulatory expectations within decontamination are in constant motion. The regulatory landscape governing decontamination is undergoing sustained and multi-dimensional change. SSD leaders are no longer just custodians of sterilisation cycles; they are now responsible for navigating a rapidly evolving framework of national technical guidance, product marking transitions, and digitally-driven audit expectations.
Increasing complexity of regulatory guidance HTM 01-01, the core technical memorandum for the management and decontamination of reusable surgical instruments, continues to
expand expectations around policy governance, equipment validation, and risk-managed operations. Multiple HTM 01-01 parts — covering management, common elements, steam sterilisation, washer-disinfectors, and alternative sterilisation methods — have been periodically updated to reflect current best practice and to align with broader UK healthcare engineering standards. This ongoing evolution requires SSDs to continuously interpret new requirements and integrate them into local policies, plant design, competency frameworks, and technical documentation.1
Product marking transitions: CE and UKCA For medical devices, Great Britain currently operates a dual-marking environment. CE- marked devices continue to be accepted under transitional arrangements — many until 30 June 2030 — and the MHRA is still developing the UK’s future medical device regulatory regime. While
the UKCA mark represents the UK’s domestic conformity pathway, the long-term direction is still under consultation, and CE marking remains strategically important for manufacturers. For SSD leaders, this means maintaining a clear understanding of device classifications, technical documentation, conformity assessment routes under UK MDR 2002 (as amended), and the role of UK Approved Bodies, particularly when working with theatres on equipment procurement and ongoing compliance.2
The rise of digital traceability as a regulatory expectation Where once compliance was primarily about accurate cycle records and well maintained log books, regulators now emphasise end-to-end digital traceability – from instrument tracking and segregation through to sterilisation and release. HTM 01-01 explicitly links compliance with robust operational management, detailed validation, and accurate record keeping across the device lifecycle. The implications are clear: compliance can no longer rely on manual systems, isolated spreadsheets, or local knowledge alone. Instead, SSDs require a fully integrated digital ecosystem, ensuring that every instrument, cycle, and workflow step is captured in structured, auditable form.
Digital documentation transforming audit readiness The shift toward digital documentation has fundamentally reshaped what it means to be “audit ready.” Modern systems: l Capture cycle parameters automatically, eliminating transcription errors.
l Provide realtime dashboards for performance, non-conformance, and throughput.
l Enforce version control on SOPs and April 2026 I
www.clinicalservicesjournal.com 81
▲
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
